PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding PharmaCyte Biotech, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 5 | 24 | +19 |
| Shares | 551.2K | 1.40M | +844.4K (+153.2%) |
| Value | $5.43K | $4.42M | +$4.42M (+81,342.2%) |
New holders (22)
Institutions that held PharmaCyte Biotech, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 1,010,146 | $3.20M | 0.70% |
| Price T Rowe Associates Inc | 133,600 | $424.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 88,200 | $280.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 49,700 | $158.0K | 0.00% |
| Geode Capital Management, LLC | 46,610 | $147.0K | 0.00% |
| NorthRock Partners, LLC | 37,164 | $118.0K | 0.01% |
| Shay Capital LLC | 14,606 | $46.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 7,070 | $22.0K | 0.00% |
| UBS Group AG | 3,401 | $11.0K | 0.00% |
| Advisor Group Holdings, Inc. | 1,763 | $6.00K | 0.00% |
| Morgan Stanley | 1,349 | $4.00K | 0.00% |
| FMR LLC | 500 | $2.00K | 0.00% |
| Royal Bank of Canada | 662 | $2.00K | 0.00% |
| Aspire Private Capital, LLC | 400 | $1.00K | 0.00% |
| Kelly Financial Services LLC | 262 | $831 | 0.00% |
| Federation des caisses Desjardins du Quebec | 7 | $22 | 0.00% |
| Bank of America Corp | 58 | $0 | 0.00% |
| Wells Fargo & Company | 26 | $0 | 0.00% |
| Harbour Investments, Inc. | 3 | $0 | 0.00% |
| Cutler Group LP | 78 | $0 | 0.00% |
| TCI Wealth Advisors, Inc. | 3 | $0 | 0.00% |
| Charter Oak Capital Management, LLC | 20 | $0 | 0.00% |
Sold out (3)
Institutions that held PharmaCyte Biotech, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Fisher Asset Management, LLC | 401,610 | $4.00K |
| Benedetti & Gucer, Inc. | 74,612 | $1.00K |
| Main Street Research LLC | 35,000 | $0 |